2019
DOI: 10.1016/j.ajem.2018.05.061
|View full text |Cite
|
Sign up to set email alerts
|

The risk stratification in community-acquired pneumonia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…Accordingly, prediction of these events early in the course of infection would represent a major advance that could enable early intervention. To this end, various investigators have assessed the utility of biomarkers, both systemic and cardiac, and risk stratification tools, such as severity of illness scores, as well as a combination of these as strategies to optimize outcome prediction in CAP patients (12,23,24). Given the absence of an ideal, single prognostic biomarker, current evidence suggests that measurement of a combination of biomarkers in CAP patients may offer the best predictive strategy.…”
Section: Cardiac Complications In All-cause Capmentioning
confidence: 99%
See 1 more Smart Citation
“…Accordingly, prediction of these events early in the course of infection would represent a major advance that could enable early intervention. To this end, various investigators have assessed the utility of biomarkers, both systemic and cardiac, and risk stratification tools, such as severity of illness scores, as well as a combination of these as strategies to optimize outcome prediction in CAP patients (12,23,24). Given the absence of an ideal, single prognostic biomarker, current evidence suggests that measurement of a combination of biomarkers in CAP patients may offer the best predictive strategy.…”
Section: Cardiac Complications In All-cause Capmentioning
confidence: 99%
“…Given the absence of an ideal, single prognostic biomarker, current evidence suggests that measurement of a combination of biomarkers in CAP patients may offer the best predictive strategy. This involves combining measurement of the systemic inflammatory biomarkers, procalcitonin (PCT) and C-reactive protein (CRP), as indices of disease severity and short-term outcome assessment, with biomarkers of CV risk such as N-terminal pro-brain natriuretic peptide (proBNP), mid-regional pro-adrenomedullin (proADM), endothelin and troponins, together with severity of illness scores, such as the CURB-65 score (12,(23)(24)(25). In this setting, it is noteworthy that the CHA2DS2-VASc score has been found to be a good predictor of new-onset atrial fibrillation in patients hospitalized for CAP (25).…”
Section: Cardiac Complications In All-cause Capmentioning
confidence: 99%
“…One of the leading factors in the pathogenesis of CAP is the excessive production of reactive oxygen intermediates (ROI), which is associated with bacterial or viral-bacterial aggression and insufficiency of the compensatory potential of antioxidant defence (AOD). An imbalance in the oxidative-antioxidant system is one of the key factors in the development of oxidative stress (OS), which plays an important role in the implementation of the molecular-cellular mechanisms of the pathogenesis of respiratory diseases [8,9]. Free radical processes are typical general biological protective reactions of the body, normally providing energy metabolism, proliferation, dif ferentiation of cells, gene expression, immune and adaptive responses, etc.…”
Section: Introductionmentioning
confidence: 99%